Internal Medicine, Medical Oncology · Richardson, TX
NPI
1528038759
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2805 E President George Bush Hwy
Richardson, TX, 75082
Phone (469) 204-6100
Groups this clinician bills Medicare through
Medicare paid, 2024
$102K
1,432 services
Medicare patients, 2024
387
Average age 76
Drug cost, 2024
$8.0M
2,449 prescriptions
Company payments, 2025
$297
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samer E Bibawi was code 99214 (office e&m - established), 661 times for 286 patients. In total Samer E Bibawi billed 1,432 services in 15 codes, and Medicare paid $102K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 661 | 286 | $83.92 | $55K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 245 | 163 | $12.55 | $3,075 |
| 99215 Office E&M - Established | Office | 112 | 89 | $117.19 | $13K |
| 99232 Hospital E&M - Subsequent | Facility | 90 | 25 | $59.06 | $5,315 |
| 99233 Hospital E&M - Subsequent | Facility | 69 | 17 | $86.16 | $5,945 |
| 99205 Office E&M - New | Office | 54 | 54 | $154.48 | $8,342 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 49 | 39 | $24.69 | $1,210 |
| 99213 Office E&M - Established | Office | 48 | 46 | $53.66 | $2,576 |
| 99211 Office E&M - Established | Office | 39 | 30 | $17.51 | $683 |
| 99223 Hospital E&M - Initial | Facility | 24 | 24 | $117.04 | $2,809 |
By year: 2022 $211K for 2,163 services; 2023 $226K for 2,341 services; 2024 $102K for 1,432 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samer E Bibawi prescribed most often to Medicare patients was Imbruvica (Ibrutinib), with 147 prescriptions and refills. In total Samer E Bibawi wrote 2,449 Medicare prescriptions that cost $8.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imbruvica Ibrutinib | 147 | 147 | 15 | $2.5M |
| Eliquis Apixaban | 137 | 205 | 29 | $116K |
| Prednisone Generic | 122 | 152 | 30 | $668 |
| Prochlorperazine Maleate Generic | 103 | 103 | 53 | $1,985 |
| Xarelto Rivaroxaban | 96 | 150 | 22 | $81K |
| Abiraterone Acetate Generic | 91 | 91 | Under 11 | $86K |
| Anastrozole Generic | 86 | 213 | 25 | $1,334 |
| Gabapentin Generic | 80 | 89 | 19 | $663 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 79 | 79 | 22 | $2,633 |
| Hydroxyurea Generic | 74 | 140 | 16 | $1,787 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 64 | 66 | 42 | $878 |
| Lenalidomide Generic | 61 | 61 | Under 11 | $902K |
| Zolpidem Tartrate Generic | 56 | 64 | 13 | $530 |
| Gammaked Immune Globul G/Gly/Iga Avg 46 | 47 | 47 | Under 11 | $212K |
| Revlimid Lenalidomide | 42 | 42 | 12 | $801K |
Brand drugs: - claims; generic drugs: 1,748 claims; opioid claims: 155.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samer E Bibawi $297 ($297 in general payments such as food, travel and fees) from 10 companies. The largest payer was Gilead Sciences, Inc. with $69.64.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 3 | $69.64 |
| Abbott Laboratories ABT | 2 | $48.74 |
| Janssen Biotech, Inc. JNJ | 2 | $34.62 |
| Sobi, Inc SOBI.ST | 1 | $26.53 |
| Abbvie Inc. ABBV | 1 | $25.07 |
| Pfizer Inc. PFE | 1 | $24.18 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $21.06 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $17.24 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $15.4 |
| Medtronic, Inc. MDT | 1 | $14.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.